Serum Levels After Everolimus-Stent Implantation and Paclitaxel-Balloon Angioplasty in an Infant with Recurrent Pulmonary Vein Obstruction After Repaired Total Anomalous Pulmonary Venous Connection

Everolimus-eluting stents and paclitaxel-coated balloons are used in the interventional treatment of coronary artery disease in adults to reduce the restenosis rate and in small-vessel disease. Both substances are released into the circulation. We report systemic drug exposure after implantation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Müller, Matthias J., Krause, Ulrich, Paul, Thomas, Schneider, Heike E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3174384/
https://www.ncbi.nlm.nih.gov/pubmed/21796444
http://dx.doi.org/10.1007/s00246-011-0054-1
_version_ 1782212066452439040
author Müller, Matthias J.
Krause, Ulrich
Paul, Thomas
Schneider, Heike E.
author_facet Müller, Matthias J.
Krause, Ulrich
Paul, Thomas
Schneider, Heike E.
author_sort Müller, Matthias J.
collection PubMed
description Everolimus-eluting stents and paclitaxel-coated balloons are used in the interventional treatment of coronary artery disease in adults to reduce the restenosis rate and in small-vessel disease. Both substances are released into the circulation. We report systemic drug exposure after implantation of one everolimus-eluting stent and dilation with one paclitaxel-coated balloon in an 8-month-old infant, which was used as an innovative therapy for recurrent pulmonary vein stenosis.
format Online
Article
Text
id pubmed-3174384
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-31743842011-09-26 Serum Levels After Everolimus-Stent Implantation and Paclitaxel-Balloon Angioplasty in an Infant with Recurrent Pulmonary Vein Obstruction After Repaired Total Anomalous Pulmonary Venous Connection Müller, Matthias J. Krause, Ulrich Paul, Thomas Schneider, Heike E. Pediatr Cardiol Case Report Everolimus-eluting stents and paclitaxel-coated balloons are used in the interventional treatment of coronary artery disease in adults to reduce the restenosis rate and in small-vessel disease. Both substances are released into the circulation. We report systemic drug exposure after implantation of one everolimus-eluting stent and dilation with one paclitaxel-coated balloon in an 8-month-old infant, which was used as an innovative therapy for recurrent pulmonary vein stenosis. Springer-Verlag 2011-07-28 2011 /pmc/articles/PMC3174384/ /pubmed/21796444 http://dx.doi.org/10.1007/s00246-011-0054-1 Text en © The Author(s) 2011 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Case Report
Müller, Matthias J.
Krause, Ulrich
Paul, Thomas
Schneider, Heike E.
Serum Levels After Everolimus-Stent Implantation and Paclitaxel-Balloon Angioplasty in an Infant with Recurrent Pulmonary Vein Obstruction After Repaired Total Anomalous Pulmonary Venous Connection
title Serum Levels After Everolimus-Stent Implantation and Paclitaxel-Balloon Angioplasty in an Infant with Recurrent Pulmonary Vein Obstruction After Repaired Total Anomalous Pulmonary Venous Connection
title_full Serum Levels After Everolimus-Stent Implantation and Paclitaxel-Balloon Angioplasty in an Infant with Recurrent Pulmonary Vein Obstruction After Repaired Total Anomalous Pulmonary Venous Connection
title_fullStr Serum Levels After Everolimus-Stent Implantation and Paclitaxel-Balloon Angioplasty in an Infant with Recurrent Pulmonary Vein Obstruction After Repaired Total Anomalous Pulmonary Venous Connection
title_full_unstemmed Serum Levels After Everolimus-Stent Implantation and Paclitaxel-Balloon Angioplasty in an Infant with Recurrent Pulmonary Vein Obstruction After Repaired Total Anomalous Pulmonary Venous Connection
title_short Serum Levels After Everolimus-Stent Implantation and Paclitaxel-Balloon Angioplasty in an Infant with Recurrent Pulmonary Vein Obstruction After Repaired Total Anomalous Pulmonary Venous Connection
title_sort serum levels after everolimus-stent implantation and paclitaxel-balloon angioplasty in an infant with recurrent pulmonary vein obstruction after repaired total anomalous pulmonary venous connection
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3174384/
https://www.ncbi.nlm.nih.gov/pubmed/21796444
http://dx.doi.org/10.1007/s00246-011-0054-1
work_keys_str_mv AT mullermatthiasj serumlevelsaftereverolimusstentimplantationandpaclitaxelballoonangioplastyinaninfantwithrecurrentpulmonaryveinobstructionafterrepairedtotalanomalouspulmonaryvenousconnection
AT krauseulrich serumlevelsaftereverolimusstentimplantationandpaclitaxelballoonangioplastyinaninfantwithrecurrentpulmonaryveinobstructionafterrepairedtotalanomalouspulmonaryvenousconnection
AT paulthomas serumlevelsaftereverolimusstentimplantationandpaclitaxelballoonangioplastyinaninfantwithrecurrentpulmonaryveinobstructionafterrepairedtotalanomalouspulmonaryvenousconnection
AT schneiderheikee serumlevelsaftereverolimusstentimplantationandpaclitaxelballoonangioplastyinaninfantwithrecurrentpulmonaryveinobstructionafterrepairedtotalanomalouspulmonaryvenousconnection

Ejemplares similares